🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,187 results for “Takeda” Clear

  1. Amoxicillin + MMX placebo

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  2. An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Lisdexamfetamine Dimesylate capsules 70 mg, manufactured by Sun Pharmaceutical Industries Limited, India with VENVANSE (lisdexamfetamine dimesylate) 70 mg Hard Gelatin Capsule, imported and registered by: Takeda Pharma Ltd. Rodovia SP 340 S/N, km 133.5, Ed. Adm. Jaguariúna-SP CNPJ 60.397.775/0001-74 and manufactured by: Patheon Pharmaceuticals Inc. Cincinnati, United States o

    Lacuna Pharma Pty Ltd

    ADHD (Attention Deficit Hyperactivity Disorder), BED (Binge Eating Disorder)

    phase 1 other active

    1 trial

  3. An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Lisdexamfetamine Dimesylate capsules 70 mg, manufactured by Sun Pharmaceutical Industries Limited, India with Elvanse (lisdexamfetamine dimesylate) 70 mg hard capsules, Marketing Authorization Holder: Takeda Pharmaceuticals International AG Ireland Branch, Block 2, Miesian Plaza, 50-58 Baggot Street Lower, Dublin 2, D02 HW68, Ireland, in healthy adult, human subjects under fas

    Lacuna Pharma Pty Ltd

    ADHD

    phase 1 other active

    1 trial

  4. An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Maribavir Tablets 200 mg, manufactured by Sun Pharmaceutical Industries Limited, India with LIVTENCITY® (Maribavir) Coated Tablets 200 mg, manufactured by: Catalent CTS, LLC Kansas City, United States of America, packed by: Takeda Ireland Limited Bray, Ireland, imported by: Takeda Pharma Ltda. Highway SP 340 S/N, km 133.5 Jaguariúna Administrative Building -SP CNPJ 60.397.775/

    Lacuna Pharma Pty Ltd

    cytomegalovirus (CMV) infection and/or disease that is refractory (with or without resistance) to one or more prior therapies in adult patients who have undergone hematopoietic stem cell transplantation (HSCT) or solid organ transplantation (SOT)

    phase 1 other active

    1 trial

  5. An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Ponatinib Tablets 15 mg, manufactured by Sun Pharmaceutical Industries Limited, India with Iclusig (Ponatinib hydrochloride) tablets 15 mg, Produced by: Patheon Inc. Mississauga, Canada or Takeda Ireland Limited Bray, Ireland, Imported and registered by: Pint Pharma Medical-Hospital and Pharmaceutical Products Ltd. Nelson Pontes Street, 125, Block 03, Jardim Margarida Zip Code

    Lacuna Pharma Pty Ltd

    chronic myeloid leukemia, Philadelphia chromosome-positive acute lymphoblastic leukemia

    phase 1 other active

    1 trial

  6. Anagrelide 0.5 mg

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  7. Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody

    Takeda

    Metastatic Adenocarcinoma of the Colon or Rectum

    phase 1 mab completed

    1 trial

  8. Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody

    Takeda

    Systemic Lupus Erythematosus

    phase 1 small molecule terminated

    1 trial

  9. Azilsartan medoxomil (TAK-491)

    Takeda

    Hypertension

    phase 1 small molecule terminated

    1 trial

  10. BAX 826

    Takeda

    Hemophilia A

    phase 1 mab completed

    1 trial

  11. Binimetinib

    Takeda

    ALK Gene Rearrangement

    phase 1 small molecule terminated

    1 trial

  12. Brentuximab Vedotin

    Takeda

    Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic

    phase 1 small molecule terminated

    1 trial

  13. Brigatinib

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  14. Budesonide

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  15. Calcichew D3

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  16. Calcitriol

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  17. Calcium 500 mg and Vitamin D3 800 IU

    Takeda

    Calcium Deficiency

    phase 1 small molecule completed

    1 trial

  18. Ciprofloxacin XR + MMX Placebo

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  19. Clarithromycin

    Takeda

    Helicobacter Pylori

    phase 1 small molecule completed

    2 trials

  20. Clopidogrel

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  21. DHAP

    Takeda

    Hodgkin Lymphoma

    phase 1 small molecule active

    1 trial

  22. Danavorexton

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  23. Daratumumab

    Takeda

    Newly Diagnosed Primary Amyloidosis

    phase 1 mab active

    1 trial

  24. Deferitazole (disodium salt, granule)

    Takeda

    Healthy

    phase 1 small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources